Literature DB >> 3334242

Structure-activity relationships amongst beta-lactamase inhibitors.

C Reading1, M Cole.   

Abstract

Using a variety of beta-lactamases including those from Escherichia coli (TEM-1), Enterobacter cloacae P99 and Staphylococcus aureus the inhibition profiles (I50 values) were determined for various groups of compounds including penicillins, penicillanic acid derivatives (sulphone and beta-halo substitutions), olivanic acids and clavulanic acid derivatives including substituted ethers and amines. Some of the latter compounds had higher activity than clavulanic acid with and without preincubation of enzyme with inhibitor but they still had poor activity against the P99 enzyme. Improvements in activity against Class I cephalosporinases were obtained with some derivatives of clavulanic acid but this was usually achieved at the expense of activity against clavulanate susceptible beta-lactamases. The olivanic acids had the highest activity against the widest range of beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3334242     DOI: 10.3109/14756368609020108

Source DB:  PubMed          Journal:  J Enzyme Inhib        ISSN: 1026-5457


  3 in total

1.  In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.

Authors:  K Coleman; D R Griffin; J W Page; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Engineering the synthetic potential of β-lactam synthetase and the importance of catalytic loop dynamics.

Authors:  Jason W Labonte; Fumitaka Kudo; Michael F Freeman; Mary L Raber; Craig A Townsend
Journal:  Medchemcomm       Date:  2012-01-01       Impact factor: 3.597

3.  Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715.

Authors:  T H Farmer; J W Page; D J Payne; D J Knowles
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.